Parke Davis and Co v Commissioner of Taxation
Case
•
[1959] HCA 15
•23 March 1959
Details
AGLC
Case
Decision Date
Parke Davis and Co v Commissioner of Taxation [1959] HCA 15
[1959] HCA 15
23 March 1959
CaseChat Overview and Summary
Parke Davis and Co (the taxpayer) appealed to the High Court of Australia against a decision of the Commissioner of Taxation concerning the assessment of income tax. The dispute centred on whether certain payments received by the taxpayer constituted assessable income under the *Income Tax Assessment Act 1936* (Cth).
The primary legal issue before the High Court was whether payments received by the taxpayer from its parent company, Parke Davis & Co (USA), were in the nature of revenue or capital. Specifically, the court had to determine if these payments, made in consideration for the taxpayer refraining from manufacturing and selling certain pharmaceutical products in Australia, were income derived from the taxpayer's business operations or a capital receipt arising from the disposal of a business asset or a restriction on its business activities.
The High Court, in a joint judgment, held that the payments were of a revenue nature and therefore assessable as income. The court reasoned that the payments were made in substitution for the profits the taxpayer would have earned had it continued to manufacture and sell the products. The restriction on the taxpayer's activities was not a disposal of a capital asset but rather a limitation on the scope of its business operations, and the compensation received was directly related to the loss of potential revenue. The court applied the principles established in cases concerning the distinction between capital and revenue receipts, focusing on the nature of the transaction and its relationship to the taxpayer's profit-making structure.
The appeal was dismissed, and the assessment of the Commissioner was upheld.
The primary legal issue before the High Court was whether payments received by the taxpayer from its parent company, Parke Davis & Co (USA), were in the nature of revenue or capital. Specifically, the court had to determine if these payments, made in consideration for the taxpayer refraining from manufacturing and selling certain pharmaceutical products in Australia, were income derived from the taxpayer's business operations or a capital receipt arising from the disposal of a business asset or a restriction on its business activities.
The High Court, in a joint judgment, held that the payments were of a revenue nature and therefore assessable as income. The court reasoned that the payments were made in substitution for the profits the taxpayer would have earned had it continued to manufacture and sell the products. The restriction on the taxpayer's activities was not a disposal of a capital asset but rather a limitation on the scope of its business operations, and the compensation received was directly related to the loss of potential revenue. The court applied the principles established in cases concerning the distinction between capital and revenue receipts, focusing on the nature of the transaction and its relationship to the taxpayer's profit-making structure.
The appeal was dismissed, and the assessment of the Commissioner was upheld.
Details
Key Legal Topics
Areas of Law
-
Tax Law
-
Statutory Interpretation
Legal Concepts
-
Statutory Construction
Actions
Download as PDF
Download as Word Document
Most Recent Citation
Brewing Investments Ltd v Federal Commissioner of Taxation [2000] FCA 34
Cases Citing This Decision
7
Federal Commissioner of Taxation v Slater Holdings Ltd
[1984] HCA 78
Esquire Nominees Ltd v Federal Commissioner of Taxation
[1973] HCA 67
Federal Commissioner of Taxation v Uther
[1965] HCA 42